In July 2021, the Gates Foundation renewed for another five years the remarkable work of the Comprehensive Cellular Vaccine Immune Monitoring Consortium (CCVIMC)opens in a new window.
Focused on supporting the development of an effective vaccine for HIV, the virus that causes AIDS, the CCVIMC convenes leading scientists to provide standardized measurements from clinical and pre-clinical studies of the disease and share data to optimize vaccine platforms being developed through the Collaboration for AIDS Vaccine Discovery.
Globally 1.5 million people are infected with HIV annually. Over the next five years the CCVIMC will continue to build on research enabling new approaches to HIV vaccines to be studied. The end goal is development of a safe and broadly effective vaccine that will prevent HIV infection.